Skip to main content
If you continue browsing this website, you agree to our policies:
  • Terms and Conditions
  • Privacy & Cookies Policy
Continue
x
  • Home
  • About
    About Open Classroom EUPATI Fellows Our Impact FAQ
  • Open Classroom
    Learning Catalogue Patient Expert Training Programme
  • Resources
    Glossary EUPATI Toolbox Patient Engagement Roadmap Accessibility Resources Patient Education Compass
  • EUPATI website
  • More
English ‎(en_wp)‎
Čeština ‎(cs)‎ Deutsch ‎(de_wp)‎ English ‎(en_wp)‎ Español ‎(es_wp)‎ Français ‎(fr_wp)‎ Italiano ‎(it_wp)‎ Nederlands ‎(nl_wp)‎ Português - Portugal ‎(pt)‎ Ελληνικά ‎(el_wp)‎
Log in

    Side Drawer

    EUPATI Open Classroom
    Profile Home About Collapse Expand
    About Open Classroom EUPATI Fellows Our Impact FAQ
    Open Classroom Collapse Expand
    Learning Catalogue Patient Expert Training Programme
    Resources Collapse Expand
    Glossary EUPATI Toolbox Patient Engagement Roadmap Accessibility Resources Patient Education Compass
    EUPATI website

    Glossary

    Back

    Toxicokinetics

    A specific type of pharmacokinetics that studies what the body does to a medicinal product at toxic doses. These studies assess how a substance enters the body and what happens to it in the body depending on the absorption, distribution, metabolism and excretion of the substance. Toxicokinetic measurements that determine the severity of toxicity are:

    • Duration and concentration of substance at the site of entry.
    • Rate and amount that can be absorbed.
    • Distribution in the body and concentration at specific sites.
    • Metabolic efficiency and nature of the metabolites.
    • Ability of the substance or its metabolites to pass through cell membranes and come into contact with specific cell components (e.g. DNA).
    • The amount and duration of storage of the substance (or its metabolites) in body tissues.
    • The rate and sites of excretion.

    Different dose levels used in toxicokinetics, compared to pharmacokinetics, give rise to technological changes in such factors as solubility, stability, absorption, pre-systemic clearance, protein binding, and metabolism that may be influenced by dose size, and may give rise to profound differences in the design and interpretation of studies.

    » Glossary

    Previous Activity
    Next Activity

    Footer

    You are not logged in. (Log in)
    Policies
    Get the mobile app
    Powered by Moodle

    About EUPATI

    • About Open Classroom
    • FAQ
    • Contact us

    Start learning

    • Learning Catalogue
    • Patient Expert Training Programme

    Resources

    • EUPATI Toolbox
    • Patient Involvement Roadmap
    • Accessibility Resources

    Terms of Use & Privacy

    • Terms and Conditions
    • Privacy and Cookie Policy

    The EUPATI Open Classroom was initially launched with support from the EUPATI Reload project, funded by EIT Health. EIT Health is supported by EIT, a body of the European Union. 

    For more information about EUPATI, please access our website www.eupati.eu or contact us at openclassroom@eupati.eu

    EIT Health logo and EU logo

    © 2025 EUPATI

    • https://eupati.eu/
    • https://www.linkedin.com/company/15178871/admin/dashboard/
    • https://www.youtube.com/user/PatientsAcademy
    • https://www.instagram.com/eupatients/
    • https://www.facebook.com/eupati.eu/
    Select banner image